The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Genomic landscapes of early-onset versus average-onset colorectal cancer populations.
 
Michael H. Storandt
No Relationships to Disclose
 
Qian Shi
Honoraria - Chugai Pharma
Consulting or Advisory Role - Hoosier Cancer Research Network; Kronos Bio; Mirati Therapeutics; Regeneron; Yiviva
Research Funding - BMS (Inst); Celgene (Inst); Janssen (Inst); Novartis (Inst); Roche/Genentech (Inst)
 
Cathy Eng
Consulting or Advisory Role - Elevar Therapeutics (Inst); Elevation Oncology; General Electric; GlaxoSmithKline; Gritstone Bio (Inst); Hutchison MediPharma (Inst); Janssen Oncology; Merck (Inst); Merck Serono; natera; Pfizer; Pfizer (Inst); Seagen
 
Christopher Hanyoung Lieu
Consulting or Advisory Role - Pfizer (Inst)
Research Funding - Merck (Inst)
 
Melissa Conrad Stoppler
Employment - Exact Sciences; Gilead Sciences (I); Roche/Genentech (I); Roche/Genentech (I); Tempus
Stock and Other Ownership Interests - Exact Sciences; Gilead Sciences (I); Roche/Genentech (I); Tempus
 
Thomas J. George
Consulting or Advisory Role - BillionToOne; Pfizer/Array; Tempus
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); BillionToOne (Inst); BioMed Valley Discoveries (Inst); Bristol-Myers Squibb (Inst); Elicio Therapeutics (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Ipsen (Inst); Jounce Therapeutics (Inst); Lilly (Inst); Merck (Inst); OncoC4 (Inst); Seagen (Inst)
 
Elizabeth Mauer
Employment - Tempus
Stock and Other Ownership Interests - Tempus
Research Funding - Tempus
Travel, Accommodations, Expenses - Tempus
 
Emily Teslow
Employment - Tempus
Travel, Accommodations, Expenses - Tempus
 
Amit Mahipal
Consulting or Advisory Role - AstraZeneca/MedImmune; QED Therapeutics; Taiho Oncology
Speakers' Bureau - AstraZeneca
Research Funding - Taiho Pharmaceutical
 
Zhaohui Jin
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Novartis (Inst); QED Therapeutics (Inst)